NHLI yields 2000000.00% · JNJ yields 2.13%● Live data
📍 NHLI pulled ahead of the other in Year 1
Combined, NHLI + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NHLI + JNJ for your $10,000?
Nouveau Holdings, Ltd., a development stage company, operates as a green mining equipment technology company. The company offers mining equipment and drilling technologies for the exploration, extraction, and environmentally conscious mining of gold, silver, and platinum. It also holds patent rights for developing laser guidance system for diamond wire stone cutting apparatus; safe system used in mineshaft illumination; continuous refractory ore bioprocessing apparatus that monitors the digestion of metal ore for silver, gold, and platinum using bacteria in a controlled agitation tank; and biomining ore processing bioreactor apparatus. In addition, Spectrum Acquisition Holdings, Inc. is developing a patent pending mixing, milling, and aeration apparatus for digesting metal ore with bacteria. The company was formerly known as Spectrum Acquisition Holdings, Inc. and changed its name to Nouveau Holdings, Ltd. in April 2013. Nouveau Holdings, Ltd. was incorporated in 1987 and is based in Austin, Texas.
Full NHLI Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.